Cellular signatures of kidney tumours

The origins of seven types of kidney cancer, including several rare subtypes, have been identified by researchers at the Wellcome Sanger Institute, Great Ormond Street Hospital (GOSH), the Princess Máxima Center for Paediatric Oncology and Oncode Institute. The findings confirm that these cancers originated in developmental cells found in the foetus. The results from the […]

read more

What is genetic testing for cancer?

This article gives a good summary of the use of genetic tests to indicate your risk of developing certain cancers, as well as the down sides of genetic testing. Genetic tests can determine whether you are at risk of developing cancer by finding mutations in a person’s genes. The risk of developing cancer increases if […]

read more

An overview of the management of rare subtypes of kidney cancer

This interview with Dr Ramaprasad Srinivasan from the National Cancer Institute in Bethesda, USA, discusses the management of sarcomatoid renal cell carcinoma (RCC), papillary RCC, and hereditary RCC, such as hereditary leiomyomatosis RCC (HLRCC). Watch the interview with Dr Srinivasan on Practice Update here

read more

Recommendations for the management of rare kidney cancers

Patients diagnosed with a rare kidney cancer are often treated the same way as clear-cell renal cell carcinoma (ccRCC) patients, despite little evidence from randomised trials. Identifying the subtype of kidney cancer by looking at the genetic make-up of tumour cells to group patients by rare kidney cancer subtype may improve outcomes. Availability of potential […]

read more
Showing all 4 results